MAnorm_2
MAnorm_2 performs quantitative differential analysis of groups of ChIP-seq samples to identify differential binding sites of chromatin-associated proteins across cellular contexts.
Key Features:
- Hierarchical Normalization Strategy: Implements a hierarchical normalization to normalize ChIP-seq signal across groups and account for variability among biological replicates and experimental conditions.
- Empirical Bayes Framework: Uses an empirical Bayes framework to assess within-group variability of ChIP-seq signals and enhance detection of true differential binding events.
- Handling Biological Replicates: Supports analysis of biological replicates to detect differential binding even between highly similar cellular contexts and subtle changes in protein–DNA interactions.
- Performance with Variable Within-Group Variability: Exhibits improved differential-detection performance relative to existing methods, particularly when comparing groups with distinct global within-group variability.
Scientific Applications:
- Inference of Differential Binding Sites: Inferring differential binding sites between cellular contexts using ChIP-seq datasets.
- Study of Transcriptional Regulation: Investigating regulation of eukaryotic gene transcription by chromatin-associated proteins through changes in binding patterns.
- Detection of Subtle Protein–DNA Interaction Changes: Detecting subtle changes in protein–DNA interactions across biological replicates and closely related cell types.
Methodology:
Preprocessing converts ChIP-seq samples into a structured format that records read abundances and enrichment states across genomic bins via the MAnorm2_utils package used alongside the main R package, followed by hierarchical normalization and empirical Bayes-based differential analysis.
Topics
Details
- License:
- GPL-3.0
- Tool Type:
- library
- Programming Languages:
- Python
- Added:
- 1/18/2021
- Last Updated:
- 2/19/2021
Operations
Publications
Tu S, Li M, Tan F, Chen H, Xu J, Waxman DJ, Zhang Y, Shao Z. MAnorm2 for quantitatively comparing groups of ChIP-seq samples. Unknown Journal. 2020. doi:10.1101/2020.01.07.896894.